US National Institutes of Health: Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)

This opportunity uses the R01 Research Project Grant funding mechanism.

This initiative will support research to determine the roles and interactions of immune cells at the maternal-fetal interface throughout pregnancy, including mechanisms of responses to vaccination and infection, or ionizing radiation, that protect or impact the fetus and that may influence fetal immune system development.

Funding & Duration

Application budgets are not limited but need to reflect the actual needs of the proposed project.

The scope of the proposed study should determine the project period. The maximum project period is 5 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.